Cencora Shares Outstanding 2012-2025 | COR
Cencora shares outstanding history from 2012 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Cencora shares outstanding for the quarter ending September 30, 2025 were 0.195B, a 2.53% decline year-over-year.
- Cencora 2025 shares outstanding were 0.195B, a 2.53% decline from 2024.
- Cencora 2024 shares outstanding were 0.2B, a 2.11% decline from 2023.
- Cencora 2023 shares outstanding were 0.205B, a 3.13% decline from 2022.
|
Cencora Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025 | 195 |
| 2024 | 200 |
| 2023 | 205 |
| 2022 | 211 |
| 2021 | 208 |
| 2020 | 205 |
| 2019 | 212 |
| 2018 | 220 |
| 2017 | 222 |
| 2016 | 226 |
| 2015 | 218 |
| 2014 | 235 |
| 2013 | 235 |
| 2012 | 257 |
| 2011 | 278 |
|
Cencora Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-09-30 | 195 |
| 2025-06-30 | 195 |
| 2025-03-31 | 195 |
| 2024-12-31 | 195 |
| 2024-09-30 | 200 |
| 2024-06-30 | 200 |
| 2024-03-31 | 201 |
| 2023-12-31 | 202 |
| 2023-09-30 | 205 |
| 2023-06-30 | 204 |
| 2023-03-31 | 204 |
| 2022-12-31 | 206 |
| 2022-09-30 | 211 |
| 2022-06-30 | 212 |
| 2022-03-31 | 212 |
| 2021-12-31 | 211 |
| 2021-09-30 | 208 |
| 2021-06-30 | 209 |
| 2021-03-31 | 207 |
| 2020-12-31 | 207 |
| 2020-09-30 | 205 |
| 2020-06-30 | 206 |
| 2020-03-31 | 207 |
| 2019-12-31 | 208 |
| 2019-09-30 | 212 |
| 2019-06-30 | 211 |
| 2019-03-31 | 213 |
| 2018-12-31 | 214 |
| 2018-09-30 | 220 |
| 2018-06-30 | 221 |
| 2018-03-31 | 222 |
| 2017-12-31 | 221 |
| 2017-09-30 | 222 |
| 2017-06-30 | 222 |
| 2017-03-31 | 221 |
| 2016-12-31 | 222 |
| 2016-09-30 | 226 |
| 2016-06-30 | 225 |
| 2016-03-31 | 225 |
| 2015-12-31 | 227 |
| 2015-09-30 | 218 |
| 2015-06-30 | 240 |
| 2015-03-31 | 220 |
| 2014-12-31 | 219 |
| 2014-09-30 | 235 |
| 2014-06-30 | 226 |
| 2014-03-31 | 236 |
| 2013-12-31 | 237 |
| 2013-09-30 | 235 |
| 2013-06-30 | 236 |
| 2013-03-31 | 235 |
| 2012-12-31 | 236 |
| 2012-09-30 | 257 |
| 2012-06-30 | 256 |
| 2012-03-31 | 262 |
| 2011-12-31 | 263 |
| 2011-09-30 | 278 |
| 2011-06-30 | 279 |
| 2011-03-31 | 280 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $68.237B | $321.333B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $170.972B | 31.39 |
| HCA Healthcare (HCA) | United States | $106.211B | 17.58 |
| CVS Health (CVS) | United States | $103.446B | 11.90 |
| Elevance Health (ELV) | United States | $82.202B | 12.06 |
| Natera (NTRA) | United States | $33.582B | 0.00 |
| DiDi Global (DIDIY) | China | $23.203B | 21.43 |
| Labcorp Holdings (LH) | United States | $22.312B | 17.01 |
| Medpace Holdings (MEDP) | United States | $17.481B | 43.40 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.574B | 0.00 |
| Viatris (VTRS) | United States | $15.031B | 5.60 |
| ICON (ICLR) | Ireland | $14.930B | 14.81 |
| BioMerieux (BMXMF) | France | $14.360B | 0.00 |
| Solventum (SOLV) | United States | $13.940B | 13.53 |
| Revvity (RVTY) | United States | $13.212B | 24.33 |
| CochLear (CHEOY) | Australia | $12.002B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.161B | 21.50 |
| Avantor (AVTR) | United States | $8.325B | 12.72 |
| Sonic Healthcare (SKHHY) | Australia | $7.861B | 0.00 |
| HealthEquity (HQY) | United States | $7.227B | 27.03 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.189B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.075B | 42.18 |
| Bausch + Lomb (BLCO) | Canada | $6.114B | 40.14 |
| PACS (PACS) | United States | $5.649B | 34.35 |
| Sotera Health (SHC) | United States | $5.392B | 26.00 |
| Alignment Healthcare (ALHC) | United States | $4.662B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.892B | 50.78 |
| Concentras Parent (CON) | United States | $2.818B | 17.59 |
| Organon (OGN) | United States | $2.493B | 2.63 |
| Progyny (PGNY) | United States | $2.194B | 43.14 |
| Surgery Partners (SGRY) | United States | $2.001B | 25.78 |
| Establishment Labs Holdings (ESTA) | United States | $1.967B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.895B | 11.32 |
| Ardent Health (ARDT) | United States | $1.223B | 3.99 |
| Teladoc Health (TDOC) | United States | $1.093B | 0.00 |
| CareDx (CDNA) | United States | $1.071B | 17.50 |
| Nutex Health (NUTX) | United States | $1.039B | 7.95 |
| Omada Health (OMDA) | United States | $0.905B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.876B | 14.33 |
| InnovAge Holding (INNV) | United States | $0.807B | 0.00 |
| Embecta (EMBC) | United States | $0.730B | 4.15 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.672B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.600B | 0.00 |
| CryoPort (CYRX) | United States | $0.550B | 0.00 |
| Enhabit (EHAB) | United States | $0.544B | 24.41 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.488B | 0.00 |
| SBC Medicals (SBC) | United States | $0.451B | 8.30 |
| Agilon Health (AGL) | United States | $0.395B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.365B | 5.87 |
| Oncology Institute (TOI) | United States | $0.332B | 0.00 |
| So-Young (SY) | China | $0.310B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.302B | 63.60 |
| Shoulder Innovations (SI) | United States | $0.296B | 0.00 |
| Beauty Health (SKIN) | United States | $0.196B | 0.00 |
| KindlyMD (NAKA) | United States | $0.181B | 0.00 |
| LifeMD (LFMD) | United States | $0.170B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.137B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.131B | 0.00 |
| Biodesix (BDSX) | United States | $0.087B | 0.00 |
| DocGo (DCGO) | United States | $0.083B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.076B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.046B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.044B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 6.34 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.015B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.005B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |